Nicotine protects against DSS colitis through regulating microRNA-124 and STAT3

Although it is generally believed that nicotine accounts for the beneficial effect of smoking on ulcerative colitis, the underlying mechanisms remain not well understood. our previous finding that nicotine inhibits inflammatory responses through inducing mir-124 prompted us to ask whether the mirna is involved in the protective action of nicotine against uc. our present study found that mir-124 expression is upregulated in colon tissues from uc patients and dss colitis mice. nicotine treatment further augmented mir-124 expression in lymphocytes isolated from human ulcerative colonic mucosa and ulcerative colon tissues from dss mice, both in infiltrated lymphocytes and epithelial cells. moreover, knockdown of mir-124 significantly diminished the beneficial effect of nicotine on murine colitis and il-6-treated caco-2 colon epithelial cells. further analysis indicated that nicotine inhibited stat3 activation in vivo and in il-6 treated caco-2 cells and jurkat human t lymphocytes, in which mir-124 knockdown led to increased activation of stat3. blocking stat3 activity alone is beneficial for dss colitis and also abolished nicotine’s protective effect in this model. these data indicate that nicotine exerts its protective action in uc through inducing mir-124 and inhibiting stat3, and suggest that the mir-124/stat3 system is a potential target for the therapeutic intervention of uc.